iShares iBoxx $ Inv Grade Corporate Bond ETF vs Pfizer Inc — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $106.32, while Pfizer Inc trades at $26.51 (market cap $151.73B). The key difference: Pfizer Inc pays a 6.46% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none, and Pfizer Inc is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| LQD | PFE | |
|---|---|---|
52-Week High | $112.91 | $28.56 |
52-Week Low | $105.96 | $23.60 |
Market Cap | — | $151.73B |
Volume | — | 29,869,932 |
Sector | — | Health |
Enterprise Value | — | $203.22B |
Dividend Yield | — | 6.46% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Trailing returns across standard periods
Latest headlines on both assets
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →